Overall Perfomance for "Shakerz and Moverz"
The following three charts can be used by potential investors to gauge the performance of "Shakerz and Moverz":
4 out of 11 campaigns closed down on first day
5 out of 11 campaigns closed up on first day
2 out of 11 campaigns had no net effect
PASO Promotional Newsletter
The following is a newsletter released by "Shakerz and Moverz" promoting Patient Access Solutions, Inc.
$PASO discusses shorting activity in Jan 2019
NEWZZZ Patient Access Solutions Inc. Issues Statement Regarding OTC Status and Trading Activity
Patient Access Solutions Inc. Issues Statement Regarding OTC Status and Trading Activity
GlobeNewswireJanuary 28, 2019
COMMACK, N.Y., Jan. 28, 2019 GLOBE NEWSWIRE -- via NEWMEDIAWIRE Patient Access Solutions, Inc. OTC PINK PASO, a provider of technology and management solutions for the healthcare industry, is pleased to inform and update shareholders on the following
OTC Market Website
Corporate Information and disclosures have been updated and submitted to OTC Market Website. The Company expects the cautionary Yield Sign to be removed shortly.
Daily Trading Activity
The Company continues to monitor trading activity and has reviewed the following available data reported by FINRA regarding short sale trades. Since January 2, 2019, the following information has been reported on
Shares Traded from January 2nd to January 25th, 2019
Date Volume Short Sales Percent Short
Jan 02 225,759 0 0.00%
Jan 03 945,557 890,785 94.21%
Jan 04 1,807,586 825,767 45.68%
Jan 07 917,669 631,896 68.85%
Jan 08 685,665 491,565 71.69%
Jan 09 1,396,334 897,419 64.27%
Jan 10 819,526 205,700 25.09%
Jan 11 323,433 108,823 33.64%
Jan 14 509,789 249,180 48.87%
Jan 15 291,099 139,720 47.99%
Jan 16 812,280 777,280 95.69%
Jan 17 299,500 229,200 76.52%
Jan 18 264,050 226,825 85.90%
Jan 22 322,351 133,701 41.47%
Jan 23 181,238 114,418 63.13%
Jan 24 71,560 60,532 84.58%
Jan 25 269,772 214,638 79.56%
Of the 10,143,168 shares traded to date for January 2019, FINRA reported 6,197,449 or 61% of the total volume as short sales. FINRA previously reported the following for the previous three months ending 2018
Month Volume Short Sales Percent Short
October 5,901,543 1,756,687 29.77%
November 6,689,782 1,571,746 23.49%
December 10,882,447 4,662,189 42.84%
As the Company announced on January 7, 2019, it has begun the process to update its financials with the auditors to become fully reporting. The Companys leadership team is working diligently to complete this process as quickly as possible to protect shareholder value as well as maintain the best level of transparency possible to the investing public.
About Patient Access Solutions Inc.www.pashealth.com
Patient Access Solutions Inc. PASHealth is a Healthcare Solutions company which has created a formidable array of technology, management resources and allies to enable it to become an agent of radical change in what has traditionally been a slowly evolving healthcare environment. For more information about the services and products of Patient Access Solutions, please visit our website at www.pashealth.com.
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things, the following general economic and business conditions competition unexpected changes in technologies and technological advances ability to commercialize and manufacture products results of experimental studies research and development activities changes in, or failure to comply with, governmental regulations and the ability to obtain adequate financing in the future. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of Patient Access Solutions Inc. Securities and Exchange Commission filings available at
PASO Investor Relations Michael Hall
Disclaimer see full disclaimer at www.shakerzandmoverz.com . SM has been compensated $2k for news dissemination. This is not a recommendation to buysell. SM has no holdings in PASO.
Copyright 2019 Shakerz and Moverz,